Most Popular in:


Email This Item! Print This Item!

Technology Transfer

By: Steve Herman
Posted: January 20, 2011, from the January 2011 issue of GCI Magazine.

page 3 of 4

In simplest terms, stimulating growth is good, but it must be carefully controlled so that growth is not out of control. Gene therapy is not the place for amateur scientists to dabble. If a therapy makes skin grow, it is critical that it does not make other body tissue grow. The small peptide fragments used in many antiaging products may have unintended results—if indeed they do work.

The frontier where Tabor works is clearly at the border of cosmetics and drugs, and shows just how deep the science gets to achieve true antiaging effects. The change is dramatic even to the untrained eye.

Claims made on antiaging ingredients in the beauty industry are plentiful, but clinical substantiation on the peer reviewed level is far less common. The methodologies expounded in the NYSCC Technology Transfer Conference, showcasing the best of academic research, is a vital key to uncovering the efficacious products of the future.

Acknowledgements: Thanks to Wes Blakeslee and Aaron Tabor, MD, of Johns Hopkins University, and Leonel Rojo of Rutgers University, for their generous cooperation in providing guidance and materials for this column.


  1. Marketing Summary C-11156.pdf,
  2. G Sun, et al, Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors, Biomaterials (2010), doi:10.1016/j.biomaterials.2010.08.091.
  3. L E Rojo et al, Wound-healing properties of nut oil from Pouteria lucuma, J Cosm Derm, 9 185–195, 2010